Data search
Results for MligTC455_44599
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_44599 | 312 | 6.49 | Mlig455_000215 | Neo: - Age: - |
PLCB4 | Mlig455_000215 {REF} {Length: 5175} {Pfam: PH domain [PF17787.3, score=118.1]; Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=38.1]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=35.8]} {Human: ENSG00000101333, PLCB4, phospholipase C beta 4, [Score=408, Expect=6e-132]} {Mouse: ENSMUSG00000039943, Plcb4, phospholipase C, beta 4, [Score=407, Expect=1e-131]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=382, Expect=9e-123]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=303, Expect=6e-93]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=525, Expect=1e-176]} {RNA1509_7348} {RNA1310_5860} {RNA815_5854} |
Cumulative graph for MligTC455_44599
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.748 | 3.059 | 0.74514 | 1.00000 | |
| RegionR2 | 0.818 | 3.059 | 0.23182 | 0.60442 | |
| RegionR3 | -0.697 | 3.059 | 0.26335 | 0.80840 | |
| RegionR4 | -0.073 | 3.059 | 0.93587 | 1.00000 | |
| RegionR5 | -0.783 | 3.059 | 0.18170 | 0.45936 | |
| RegionR6 | -0.332 | 3.059 | 0.58507 | 1.00000 | |
| RegionR7 | -0.891 | 3.059 | 0.37890 | 1.00000 | |
| RegionR8 | 1.209 | 3.059 | 0.21111 | 0.81499 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.249 | 3.059 | 0.92023 | 1.00000 | |
| RegenerationR2 | 0.17 | 3.059 | 0.68304 | 0.94986 | |
| RegenerationR3 | 0.733 | 3.059 | 0.22150 | 0.65686 | |
| RegenerationR4 | 0.288 | 3.059 | 0.63303 | 0.92445 | |
| RegenerationR5 | 0.599 | 3.059 | 0.25656 | 0.68891 | |
| RegenerationR6 | 0.939 | 3.059 | 0.09568 | 0.38457 | |
| RegenerationBL | 0.29 | 3.059 | 0.69683 | 1.00000 | |
| RegenerationTP | -0.389 | 3.059 | 0.67357 | 1.00000 |
Genes with expression patterns similar to MligTC455_44599
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_44599 | 312 | 6.49 | Mlig455_000215 | Neo: - Age: - |
PLCB4 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_000215 {REF} {Length: 5175} {Pfam: PH domain [PF17787.3, score=118.1]; Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=38.1]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=35.8]} {Human: ENSG00000101333, PLCB4, phospholipase C beta 4, [Score=408, Expect=6e-132]} {Mouse: ENSMUSG00000039943, Plcb4, phospholipase C, beta 4, [Score=407, Expect=1e-131]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=382, Expect=9e-123]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=303, Expect=6e-93]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=525, Expect=1e-176]} {RNA1509_7348} {RNA1310_5860} {RNA815_5854} |
| 2. | MligTC455_43272 | 467 | 9.73 | Mlig455_007706, Mlig455_021038 | Neo: - Age: - Region-enriched R4: 2.849/0.04948 Regeneration-upregulated BL: 3.619 Regeneration-enriched BL: 3.619 |
1.788 | 0.826 | - | - | - | 0.962 | - | Mlig455_007706 {REF} {Length: 2491} {Pfam: Galactose binding lectin domain [PF02140.20, score=41.5]} {RNA1509_51594} {RNA1310_25581} {RNA815_37571} Mlig455_021038 {REF} {Length: 3071} {Pfam: Galactose binding lectin domain [PF02140.20, score=41.6]} {RNA1509_51594} {RNA1310_25581, RNA1509_51594} {RNA1509_51594, RNA815_37571} |
|
| 3. | MligTC455_11255 | 393 | 8.18 | Mlig455_014776 | Neo: - Age: Down-Up-Up |
DUSP12 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_014776 {REF} {Length: 2388} {TRANSSPLICED} {Pfam: Dual specificity phosphatase, catalytic domain [PF00782.22, score=92.9]} {Human: ENSG00000081721, DUSP12, dual specificity phosphatase 12, [RH, Score=191, Expect=1e-57]} {Mouse: ENSMUSG00000026659, Dusp12, dual specificity phosphatase 12, [RH, Score=188, Expect=7e-57]} {Dmel: FBgn0031044, MKP-4, MAPK Phosphatase 4, [RH, Score=145, Expect=5e-40]} {Celegans: WBGene00007697, C24F3.2, [RH, Score=83.6, Expect=2e-18]} {Smed: dd_Smed_v6_7025_0_1, dd_Smed_v6_7025_0_1, [RH, Score=169, Expect=1e-50]} {RNA1509_13683, RNA1509_45246} {RNA1310_28181.1, RNA1509_13683, RNA1509_45246} {RNA1509_13683, RNA1509_45246, RNA815_10489} |
| 4. | MligTC455_23028 | 249 | 5.19 | Mlig455_032094 | Neo: - Age: - |
ABL1 | 0.959 | - | - | - | 0.959 | - | - | Mlig455_032094 {REF} {Length: 6567} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=320.2]; Protein kinase domain [PF00069.27, score=154.6]; SH2 domain [PF00017.26, score=79.1]; F-actin binding [PF08919.12, score=34.4]; Variant SH3 domain [PF14604.8, score=23.6]; SH3 domain [PF00018.30, score=20.3]} {Human: ENSG00000097007, ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, [RH, Score=551, Expect=3e-177]; ENSG00000143322, ABL2, ABL proto-oncogene 2, non-receptor tyrosine kinase, [RH, Score=545, Expect=4e-176]} {Mouse: ENSMUSG00000026842, Abl1, c-abl oncogene 1, non-receptor tyrosine kinase, [RH, Score=551, Expect=6e-178]; ENSMUSG00000026596, Abl2, v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene), [RH, Score=540, Expect=4e-174]} {Dmel: FBgn0000017, Abl, Abl tyrosine kinase, [RH, Score=548, Expect=6e-172]} {Celegans: WBGene00000018, abl-1, Tyrosine-protein kinase abl-1, [RH, Score=517, Expect=3e-164]} {Smed: dd_Smed_v6_4352_0_1, dd_Smed_v6_4352_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_21216} {RNA1310_7858} {RNA815_21818} |
| 5. | MligTC455_03268 | 213 | 4.43 | Mlig455_070869 | Neo: - Age: - |
KCTD16 | 0.951 | - | - | 0.951 | - | - | - | Mlig455_070869 {REF} {Length: 1233} {Pfam: BTB/POZ domain [PF02214.24, score=57.6]} {Human: ENSG00000183775, KCTD16, potassium channel tetramerization domain containing 16, [RH, Score=174, Expect=1e-51]; ENSG00000178695, KCTD12, potassium channel tetramerization domain containing 12, [RH, Score=166, Expect=2e-49]} {Mouse: ENSMUSG00000051401, Kctd16, potassium channel tetramerisation domain containing 16, [RH, Score=176, Expect=2e-52]} {Dmel: FBgn0038839, Ktl, Kctd12-like, [RH, Score=251, Expect=3e-84]} {Celegans: WBGene00014848, VM106R.1, [RH, Score=178, Expect=6e-55]} {Smed: dd_Smed_v6_12440_0_1, dd_Smed_v6_12440_0_1, [RH, Score=242, Expect=5e-81]} {RNA1310_34396} {RNA815_14650} |
| 6. | MligTC455_34997 | 516 | 10.75 | Mlig455_060069 | Neo: - Age: - |
ABHD13 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_060069 {REF} {Length: 2251} {TRANSSPLICED} {Pfam: Serine aminopeptidase, S33 [PF12146.10, score=45.9]; alpha/beta hydrolase fold [PF00561.22, score=42.3]; Alpha/beta hydrolase family [PF12697.9, score=31.3]; Acetyl xylan esterase (AXE1) [PF05448.14, score=23.5]; alpha/beta hydrolase fold [PF07859.15, score=19.8]} {Human: ENSG00000139826, ABHD13, abhydrolase domain containing 13, [RH, Score=223, Expect=2e-68]} {Mouse: ENSMUSG00000040396, Abhd13, abhydrolase domain containing 13, [RH, Score=239, Expect=7e-75]} {Dmel: FBgn0025109, Bem46, [RH, Score=219, Expect=3e-67]} {Celegans: WBGene00045192, aho-3, [Score=100, Expect=2e-23]} {Smed: dd_Smed_v6_6717_0_1, dd_Smed_v6_6717_0_1, [RH, Score=247, Expect=4e-78]} {RNA1509_14735, RNA1509_34001} {RNA1310_20836, RNA1509_34001} {RNA1509_34001, RNA815_14136} |
Berezikov Lab - 2020-2021 © ERIBA